Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk
Year: 2020
Type: article
Abstract: We describe the institutional guidelines of a major tertiary cancer center with regard to using hypofractionated radiation regimens to treat glioblastoma as a measure to minimize exposure to coronavirus disease 2019 (COVID-19) while not sacrificing clinical outcomes. Our guidelines review level one evidence of various hypofractionated regimens, and recommend a multidisciplinary approach while balancing the risk of morbidity and mortality among individuals at high risk for severe illness from COVID-19 infection. We also briefly outline strategies our department is taking in mitigating risk among our cancer patients undergoing radiation.
Source: Advances in Radiation Oncology
Authors: Sonal S. Noticewala, Ethan B. Ludmir, Andrew J. Bishop, Caroline Chung, Amol J. Ghia, David Grosshans, Susan McGovern, Arnold de la Cruz Paulino, Chenyang Wang, Kristina D. Woodhouse, Debra N. Yeboa, Sujit S. Prabhu, Shiao-Pei Weathers, Prajnan Das, Albert C. Koong, Mary Frances McAleer, Jing Li
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,000
OpenAlex ID: W3032673983